NFE2L2 and familial pancreatic carcinoma: Recently, Fu and coworkers demonstrated that CUR enhances the antitumor growth effect of sestrin2 through the Nrf-2-Keap1/HO-1/NQO-1 signaling pathway in pancreatic cancer cells [96].